Abstract:Background: Multiple sclerosis (MS) is a central nervous system (CNS) demyelinating autoimmune disease with increasing global prevalence. It predominantly affects females, especially those of European descent. The interplay between environmental factors and genetic predisposition plays a crucial role in MS etiopathogenesis. Methods: We searched recent relevant literature on reputable databases, which include, PubMed, Embase, Web of Science, Scopus, and ScienceDirect using the following keywords: multiple sclerosis, pathogenesis, autoimmunity, demyelination, therapy, and immunotherapy. Results: Various animal models have been employed to investigate the MS etiopathogenesis and therapeutics. Autoreactive T cells within the CNS recruit myeloid cells through chemokine expression, leading to the secretion of inflammatory cytokines driving the MS pathogenesis, resulting in demyelination, gliosis, and axonal loss. Key players include T cell lymphocytes (CD4+ and CD8+), B cells, and neutrophils. Signaling dysregulation in inflammatory pathways and the immunogenetic basis of MS are essential considerations for any successful therapy to MS. Data indicates that B cells and neutrophils also have significant roles in MS, despite the common belief that T cells are essential. High neutrophil-to-lymphocyte ratios correlate with MS severity, indicating their contribution to disease progression. Dysregulated signaling pathways further exacerbate MS progression. Conclusion: MS remains incurable, but disease-modifying therapies, monoclonal antibodies, and immunomodulatory drugs offer hope for patients. Research on the immunogenetics and immunoregulatory functions of gut microbiota is continuing to provide light on possible treatment avenues. Understanding the complex interplay between genetic predisposition, environmental factors, and immune dysregulation is critical for developing effective treatments for MS.

Advances in research of the role of microglia polarization in the mechanisms of pathogenesis of multiple sclerosis

The roles of macrophages and microglia in multiple sclerosis and experimental autoimmune encephalomyelitis

Polarization of Microglia to the M2 Phenotype in A Peroxisome Proliferator-Activated Receptor Gamma-Dependent Manner Attenuates Axonal Injury Induced by Traumatic Brain Injury in Mice

[Micrornas in Microglia Polarization and CNS Diseases: Mechanism and Functions].

Microglia Polarization From M1 to M2 in Neurodegenerative Diseases

Microglial polarization: novel therapeutic mechanism against Alzheimer’s disease

Modulating the polarization phenotype of microglia - A valuable strategy for central nervous system diseases

Modulation of the Microglial Nogo-A/NgR Signaling Pathway as a Therapeutic Target for Multiple Sclerosis

Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis

Role of Microglia in Neurological Disorders and Their Potentials As a Therapeutic Target

Advances in the research of the role of macrophage/microglia polarization-mediated inflammatory response in spinal cord injury

Microglia Polarization in Alzheimer’s Disease: Mechanisms and a Potential Therapeutic Target

Recent Progress in Multiple Sclerosis Treatment Using Immune Cells as Targets

MicroRNAs associated with the pathogenesis of multiple sclerosis

The effects and potential of microglial polarization and crosstalk with other cells of the central nervous system in the treatment of Alzheimer’s disease

Focus on the Role of the NLRP3 Inflammasome in Multiple Sclerosis: Pathogenesis, Diagnosis, and Therapeutics

Immunopathogenesis of multiple sclerosis: molecular and cellular mechanisms and new immunotherapeutic approaches

Mirnas Participate in MS Pathological Processes and Its Therapeutic Response

Microglia and Multiple Sclerosis

miRNAs Participate in MS Pathological Processes and Its Therapeutic Response.

Glial Cells as Key Regulators in Neuroinflammatory Mechanisms Associated with Multiple Sclerosis